Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 22 September 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Efficacy of antireflux surgery in patients with estraesophageal reflux

The most recent issue of the Clinical Gastroenterology & Hepatology examines the association between response to acid-suppression therapy and efficacy of antireflux surgery in patients with extraesophageal reflux.

News image

The effectiveness of antireflux surgery varies among patients with extraesophageal manifestations of gastroesophageal reflux disease (GERD). 

By studying a cohort of patients with primary extraesophageal symptoms and abnormal physiologic markers for GERD, Dr Michael Vaeziwe and colleagues from Tennessee identified factors associated with positive outcomes from surgery, and compare outcomes to those with typical esophageal manifestations of GERD.

The researchers performed a retrospective cohort study comparing adult patients with extraesophageal and typical reflux symptoms who underwent de novo antireflux surgery from 2004 through 2012 at a tertiary care center. 

All 115 patients had evidence of abnormal distal esophageal acid exposure based on pH testing or endoscopy. 

The team's principle outcome was time to primary symptom recurrence after surgery, based on patient reports of partial or total recurrence of symptoms at follow-up visits. 

Patients were followed up for a median duration of 66 months.

Hiatal hernia size was not associated with symptom response
Clinical Gastroenterology & Hepatology
The team's median time to recurrence of symptoms in the overall cohort was 68 months. 

Symptom recurrence after antireflux surgery was associated with having primarily extraesophageal symptoms, and poor preoperative symptom response to acid-suppression therapy.

The researchers found that patients with primary extraesophageal symptoms who had a full or partial preoperative acid-suppression therapy response experienced lower rates of symptom recurrence compared to patients with poor acid-suppression therapy response. 

The rate of symptom recurrence was lowest among patients with primary typical reflux symptoms who had a partial or full symptom response to acid-suppression therapy. 

The team noted that severity of acid reflux on pH testing, symptom indices, severity of esophagitis, and hiatal hernia size were not associated with symptom response.

Dr Vaeziwe's team concludes, "In a retrospective study, we found the effectiveness of antireflux surgery to be less predictable in patients with extraesophageal symptoms of GERD than in patients with typical GERD."

"Response to acid-suppression therapy before surgery was associated with antireflux surgery effectiveness in patients with extraesophageal reflux symptoms."

"Caution should be exercised when advocating antireflux surgery for patients with extraesophageal symptoms that do not respond to acid-suppression therapy."

Clin Gastroenterol Hepatol 2017: 15(5): 675–681
08 June 2017

Go to top of page Email this page Email this page to a colleague

 22 September 2017 
MRI for liver metastatic colorectal cancer
 22 September 2017 
Perforation after colonic endoscopic mucosal resection
 22 September 2017 
Medical management and colectomy rates
 21 September 2017 
Predicting mucosal healing in treated celiac disease patients
 21 September 2017 
Antireflux surgery and recurrence of GERD
 21 September 2017 
Adenomatous colorectal polyps in young cancer survivors
 20 September 2017 
Rifaximin and spontaneous bacterial peritonitis in cirrhosis
 20 September 2017 
Omega-3 PUFA and colorectal cancer survival
 20 September 2017 
Beta-blockers and cardiopulmonary exercise testing in liver disease
 19 September 2017 
Birth outcomes in children fathered by men treated with azathioprine
 19 September 2017 
Risk of death and statins in alcoholic cirrhosis
 19 September 2017 
Hospital-readmission risk
 18 September 2017 
Ethnic disparities and Hep C survival
 18 September 2017 
Depression and celiac disease in the USA
 18 September 2017 
Health care services in IBD
 15 September 2017 
Hemidesmosome integrity and colorectal cancer
 15 September 2017 
Herpes zoster vaccination in IBD
 15 September 2017 
Chronic pancreatitis and pancreatic cancer risk
 14 September 2017 
National survey on stopping PPIs
 14 September 2017 
Psychological impact of IBD
 14 September 2017 
Bile tree pathology in patients presenting with gallbladder disease
 13 September 2017 
Predicting clinical outcome in colorectal cancer
 13 September 2017 
Oral contraceptives increases the risk of IBD
 13 September 2017 
Mortality in cirrhosis
 12 September 2017 
Genetic factors and tobacco in IBD
 12 September 2017 
Predictors of colectomy in ulcerative colitis
 12 September 2017 
Low birthweight and pediatric NAFLD
 11 September 2017 
Proteomic analysis of IBD
 11 September 2017 
New therapies to manage Hep B
 11 September 2017 
Ethnic disparities for chronic Hep C survival
 08 September 2017 
Antibiotics and diverticulitis
 08 September 2017 
Improving adherence to colorectal cancer screening
 08 September 2017 
Preoperative workup for colorectal cancer
 07 September 2017 
Laparoscopic surgery use in Medicare patients with colon cancer
 07 September 2017 
Outreach to improve colorectal cancer screening
 07 September 2017 
Nicotine chewing gum after colorectal surgery
 06 September 2017 
Novel candidate risk genes for IBD
 06 September 2017 
PPI use and chronic kidney disease
 06 September 2017 
Colorectal cancer surgery in the very elderly patient
 05 September 2017 
Unprovoked Venous Thromboembolism and occult cancer
 05 September 2017 
Hep E seroprevalence and hemodialysis
 05 September 2017 
Antibody tests and detecting celiac disease
 04 September 2017 
Acute pancreatitis and health related quality of life
 04 September 2017 
Infliximab treatment and eHealth in IBD
 04 September 2017 
Contrast-enhanced ultrasound for diagnosis of liver cancer
 01 September 2017 
Late recurrence of Barrett’s esophagus after eradication
 01 September 2017 
Thalidomide ine children with IBD
 01 September 2017 
Occult cancer screening with unprovoked venous thromboembolism
 31 August 2017 
Asthma and IBD development
 31 August 2017 
Environmental factors and IBD
 31 August 2017 
Management of noncardiac chest pain
 30 August 2017 
Diet and increased flares in patients with ulcerative colitis in remission
 30 August 2017 
Induction of remission in pediatric Crohn's disease
 29 August 2017 
Reducing antibody formation against TNF antagonists in IBD
 29 August 2017 
Epidemiological changes of chronic hepatitis
 28 August 2017 
Hyperuricemia and NAFLD activity score
 28 August 2017 
Therapy for acute variceal hemorrhage
 28 August 2017 
Colectomy rates in ulcerative colitis
 25 August 2017 
Making personalized nutrition a reality
 25 August 2017 
Predicting advanced colorectal cancer survival

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us